ニキビ対策化粧品の市場規模、シェア、動向分析レポート:製品タイプ別(マスク、クリーム&ローション、クレンザー&トナー)、性別(女性、男性)、エンドユース別(皮膚科クリニック)、地域別、セグメント別予測、2023年~2030年Anti-acne Cosmetics Market Size, Share & Trends Analysis Report By Product Type (Masks, Creams & Lotions, Cleansers & Toners), By Gender (Women, Men), By End-use (Dermatology Clinics), By Region, And Segment Forecasts, 2023 - 2030 抗ニキビ化粧品市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界の抗ニキビ化粧品市場規模は、2023年から2030年にかけて年平均成長率9.1%を記録し、2030年には89.1億米ドルに達する... もっと見る
本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。
サマリー抗ニキビ化粧品市場の成長と動向Grand View Research, Inc.の最新レポートによると、世界の抗ニキビ化粧品市場規模は、2023年から2030年にかけて年平均成長率9.1%を記録し、2030年には89.1億米ドルに達すると予測されている。特に女性の間で、にきびに関連する高い心理的負担が市場の主要な成長促進要因になると予想される。さらに、にきびを治療するための様々な製品が容易に入手可能であることが、市場の成長をサポートすると予測されている。米国皮膚科学会によると、にきびは米国で一般的な皮膚疾患の一つであり、毎年約5,000万人が罹患しており、12~24歳の85%近くが軽度のにきびを患っている。従って、この皮膚疾患の有病率の高さも製品需要を煽り、市場成長を増大させると予想される。 さらに、SkinStoreの調査によると、平均的なアメリカ人女性は1日に16種類近くのスキンケア製品を使用し、毎日約8米ドルを顔用化粧品に費やしている。このような美容法も市場成長を促進すると予想されている。リムリック大学の研究によると、この皮膚障害に関連する社会的烙印は、個人の生活の質を低下させ、心理的苦痛を増大させ、頭痛、睡眠障害、胃腸障害などの身体的問題を引き起こす。このことも、今後数年間の製品需要の増加につながると予想される。 抗ニキビ化粧品市場レポートハイライト - クリームはあらゆるタイプのにきびに対する治療の第一線であり、また皮膚に保湿を与えるため、2022年にはクリーム&ローション部門が全体の収益の41.55%という最大シェアを占めた。 - その他の製品セグメントは、クリーム&ローションに比べて肌への負担が軽く、様々な肌タイプに適合することから、予測期間中に最も速いCAGRを記録すると予想されている。 - にきびやその他の皮膚疾患の有病率が高いことから、2022年の世界市場は女性用にきび対策化粧品セグメントが売上高で52.8%のシェアを占め、予測期間中最も速いCAGR 9.3%で拡大する見込みである。 - アジア太平洋地域は、可処分所得水準の向上と発展途上国の人口増加により、2022年の売上高シェアで40%以上を占め、予測期間中に力強い成長が見込まれる。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Type 1.1.2. Gender 1.1.3. End use 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.4. Information or Data Analysis 1.5. Market Formulation & Validation 1.6. Model Details 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Type outlook 2.2.2. Gender outlook 2.2.3. End-use outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Anti-acne Cosmetics Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Market Dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.4. Anti-acne Cosmetics Market Analysis Tools 3.4.1. Industry Analysis - Porter’s Five Forces 3.4.1.1. Supplier power 3.4.1.2. Buyer power 3.4.1.3. Substitution threat 3.4.1.4. Threat of new entrant 3.4.1.5. Competitive rivalry 3.4.2. PESTEL Analysis 3.4.2.1. Political landscape 3.4.2.2. Technological landscape 3.4.2.3. Economic landscape Chapter 4. Anti-acne Cosmetics Market: Type Estimates & Trend Analysis 4.1. Anti-acne Cosmetics Market: Key Takeaways 4.2. Anti-acne Cosmetics Market: Type Movement & Market Share Analysis, 2022 & 2030 4.3. Mask 4.3.1. Masks market estimates and forecasts, 2018 to 2030 (USD Million) 4.4. Creams & Lotions 4.4.1. Creams & lotions market estimates and forecasts, 2018 to 2030 (USD Million) 4.5. Cleanser & Toner 4.5.1. Cleanser & Toner market estimates and forecasts, 2018 to 2030 (USD Million) 4.6. Others 4.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 5. Anti-acne Cosmetics Market: Gender Estimates & Trend Analysis 5.1. Anti-acne Cosmetics Market: Key Takeaways 5.2. Anti-acne Cosmetics Market: Gender Movement & Market Share Analysis, 2022 & 2030 5.3. Women 5.3.1. Women market estimates and forecasts, 2018 to 2030 (USD Million) 5.4. Men 5.4.1. Men market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 6. Anti-acne Cosmetics Market: End-use Estimates & Trend Analysis 6.1. Anti-acne Cosmetics Market: Key Takeaways 6.2. Anti-acne Cosmetics Market: End-use Movement & Market Share Analysis, 2022 & 2030 6.3. Med Spa 6.3.1. Med spa market estimates and forecasts, 2018 to 2030 (USD Million) 6.4. Dermatology Clinics 6.4.1. Dermatology clinics market estimates and forecasts, 2018 to 2030 (USD Chapter 7. Anti-acne Cosmetics Market: Regional Estimates & Trend Analysis 7.1. Regional Outlook 7.2. Anti-acne Cosmetics Market by Region: Key Marketplace Takeaways 7.3. North America 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.3.2. U.S. 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.3.3. Canada 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4. Europe 7.4.1. UK 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.2. Germany 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.3. France 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.4. Italy 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.5. Spain 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.6. Sweden 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.7. Norway 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.8. Denmark 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5. Asia Pacific 7.5.1. Japan 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.2. China 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.3. India 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.4. Australia 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.5. Thailand 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.6. South Korea 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6. Latin America 7.6.1. Brazil 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6.2. Mexico 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6.3. Argentina 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7. MEA 7.7.1. Saudi Arabia 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.2. South Africa 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.3. UAE 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.4. Kuwait 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Market Participant Categorization 8.2.1. L’ORÉAL PARIS 8.2.1.1. Company overview 8.2.1.2. Financial performance 8.2.1.3. Product benchmarking 8.2.1.4. Strategic initiatives 8.2.2. MURAD LLC (UNILEVER) 8.2.2.1. Company overview 8.2.2.2. Financial performance 8.2.2.3. Product benchmarking 8.2.2.4. Strategic initiatives 8.2.3. NEUTROGENA (JOHNSON & JOHNSON SERVICES, INC.) 8.2.3.1. Company overview 8.2.3.2. Financial performance 8.2.3.3. Product benchmarking 8.2.3.4. Strategic initiatives 8.2.4. CLINIQUE LABORATORIES, LLC (ESTEE LAUDER) 8.2.4.1. Company overview 8.2.4.2. Financial performance 8.2.4.3. Product benchmarking 8.2.4.4. Strategic initiatives 8.2.5. VICHY LABORATORIES 8.2.5.1. Company overview 8.2.5.2. Financial performance 8.2.5.3. Product benchmarking 8.2.5.4. Strategic initiatives 8.2.6. PCA SKIN 8.2.6.1. Company overview 8.2.6.2. Financial performance 8.2.6.3. Product benchmarking 8.2.6.4. Strategic initiatives 8.2.7. OBAGI 8.2.7.1. Company overview 8.2.7.2. Financial performance 8.2.7.3. Product benchmarking 8.2.7.4. Strategic initiatives 8.2.8. JAN MARINI SKIN RESEARCH 8.2.8.1. Company overview 8.2.8.2. Financial performance 8.2.8.3. Product benchmarking 8.2.8.4. Strategic initiatives 8.2.9. PHYTOMER 8.2.9.1. Company overview 8.2.9.2. Financial performance 8.2.9.3. Product benchmarking 8.2.9.4. Strategic initiatives 8.2.10. COLORESCIENCE, INC 8.2.10.1. Company overview 8.2.10.2. Financial performance 8.2.10.3. Product benchmarking 8.2.10.4. Strategic initiatives 8.2.11. SKINMEDICA, INC. 8.2.11.1. Company overview 8.2.11.2. Financial performance 8.2.11.3. Product benchmarking 8.2.11.4. Strategic initiatives 8.2.12. SKINBETTER SCIENCE 8.2.12.1. Company overview 8.2.12.2. Financial performance 8.2.12.3. Product benchmarking 8.2.12.4. Strategic initiatives 8.2.13. SENTE 8.2.13.1. Company overview 8.2.13.2. Financial performance 8.2.13.3. Product benchmarking 8.2.13.4. Strategic initiatives 8.2.14. GLOWBIOTICS LLC 8.2.14.1. Company overview 8.2.14.2. Financial performance 8.2.14.3. Product benchmarking 8.2.14.4. Strategic initiatives 8.2.15. PERRICONE MD 8.2.15.1. Company overview 8.2.15.2. Financial performance 8.2.15.3. Product benchmarking 8.2.15.4. Strategic initiatives 8.2.16. THE BEAUTYHEALHTH COMPANY 8.2.16.1. Company overview 8.2.16.2. Financial performance 8.2.16.3. Product benchmarking 8.2.16.4. Strategic initiatives
SummaryAnti-acne Cosmetics Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Type 1.1.2. Gender 1.1.3. End use 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.4. Information or Data Analysis 1.5. Market Formulation & Validation 1.6. Model Details 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Type outlook 2.2.2. Gender outlook 2.2.3. End-use outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Anti-acne Cosmetics Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Market Dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.4. Anti-acne Cosmetics Market Analysis Tools 3.4.1. Industry Analysis - Porter’s Five Forces 3.4.1.1. Supplier power 3.4.1.2. Buyer power 3.4.1.3. Substitution threat 3.4.1.4. Threat of new entrant 3.4.1.5. Competitive rivalry 3.4.2. PESTEL Analysis 3.4.2.1. Political landscape 3.4.2.2. Technological landscape 3.4.2.3. Economic landscape Chapter 4. Anti-acne Cosmetics Market: Type Estimates & Trend Analysis 4.1. Anti-acne Cosmetics Market: Key Takeaways 4.2. Anti-acne Cosmetics Market: Type Movement & Market Share Analysis, 2022 & 2030 4.3. Mask 4.3.1. Masks market estimates and forecasts, 2018 to 2030 (USD Million) 4.4. Creams & Lotions 4.4.1. Creams & lotions market estimates and forecasts, 2018 to 2030 (USD Million) 4.5. Cleanser & Toner 4.5.1. Cleanser & Toner market estimates and forecasts, 2018 to 2030 (USD Million) 4.6. Others 4.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 5. Anti-acne Cosmetics Market: Gender Estimates & Trend Analysis 5.1. Anti-acne Cosmetics Market: Key Takeaways 5.2. Anti-acne Cosmetics Market: Gender Movement & Market Share Analysis, 2022 & 2030 5.3. Women 5.3.1. Women market estimates and forecasts, 2018 to 2030 (USD Million) 5.4. Men 5.4.1. Men market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 6. Anti-acne Cosmetics Market: End-use Estimates & Trend Analysis 6.1. Anti-acne Cosmetics Market: Key Takeaways 6.2. Anti-acne Cosmetics Market: End-use Movement & Market Share Analysis, 2022 & 2030 6.3. Med Spa 6.3.1. Med spa market estimates and forecasts, 2018 to 2030 (USD Million) 6.4. Dermatology Clinics 6.4.1. Dermatology clinics market estimates and forecasts, 2018 to 2030 (USD Chapter 7. Anti-acne Cosmetics Market: Regional Estimates & Trend Analysis 7.1. Regional Outlook 7.2. Anti-acne Cosmetics Market by Region: Key Marketplace Takeaways 7.3. North America 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.3.2. U.S. 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.3.3. Canada 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4. Europe 7.4.1. UK 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.2. Germany 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.3. France 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.4. Italy 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.5. Spain 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.6. Sweden 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.7. Norway 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.4.8. Denmark 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5. Asia Pacific 7.5.1. Japan 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.2. China 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.3. India 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.4. Australia 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.5. Thailand 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.5.6. South Korea 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6. Latin America 7.6.1. Brazil 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6.2. Mexico 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.6.3. Argentina 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7. MEA 7.7.1. Saudi Arabia 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.2. South Africa 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.3. UAE 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 7.7.4. Kuwait 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Market Participant Categorization 8.2.1. L’ORÉAL PARIS 8.2.1.1. Company overview 8.2.1.2. Financial performance 8.2.1.3. Product benchmarking 8.2.1.4. Strategic initiatives 8.2.2. MURAD LLC (UNILEVER) 8.2.2.1. Company overview 8.2.2.2. Financial performance 8.2.2.3. Product benchmarking 8.2.2.4. Strategic initiatives 8.2.3. NEUTROGENA (JOHNSON & JOHNSON SERVICES, INC.) 8.2.3.1. Company overview 8.2.3.2. Financial performance 8.2.3.3. Product benchmarking 8.2.3.4. Strategic initiatives 8.2.4. CLINIQUE LABORATORIES, LLC (ESTEE LAUDER) 8.2.4.1. Company overview 8.2.4.2. Financial performance 8.2.4.3. Product benchmarking 8.2.4.4. Strategic initiatives 8.2.5. VICHY LABORATORIES 8.2.5.1. Company overview 8.2.5.2. Financial performance 8.2.5.3. Product benchmarking 8.2.5.4. Strategic initiatives 8.2.6. PCA SKIN 8.2.6.1. Company overview 8.2.6.2. Financial performance 8.2.6.3. Product benchmarking 8.2.6.4. Strategic initiatives 8.2.7. OBAGI 8.2.7.1. Company overview 8.2.7.2. Financial performance 8.2.7.3. Product benchmarking 8.2.7.4. Strategic initiatives 8.2.8. JAN MARINI SKIN RESEARCH 8.2.8.1. Company overview 8.2.8.2. Financial performance 8.2.8.3. Product benchmarking 8.2.8.4. Strategic initiatives 8.2.9. PHYTOMER 8.2.9.1. Company overview 8.2.9.2. Financial performance 8.2.9.3. Product benchmarking 8.2.9.4. Strategic initiatives 8.2.10. COLORESCIENCE, INC 8.2.10.1. Company overview 8.2.10.2. Financial performance 8.2.10.3. Product benchmarking 8.2.10.4. Strategic initiatives 8.2.11. SKINMEDICA, INC. 8.2.11.1. Company overview 8.2.11.2. Financial performance 8.2.11.3. Product benchmarking 8.2.11.4. Strategic initiatives 8.2.12. SKINBETTER SCIENCE 8.2.12.1. Company overview 8.2.12.2. Financial performance 8.2.12.3. Product benchmarking 8.2.12.4. Strategic initiatives 8.2.13. SENTE 8.2.13.1. Company overview 8.2.13.2. Financial performance 8.2.13.3. Product benchmarking 8.2.13.4. Strategic initiatives 8.2.14. GLOWBIOTICS LLC 8.2.14.1. Company overview 8.2.14.2. Financial performance 8.2.14.3. Product benchmarking 8.2.14.4. Strategic initiatives 8.2.15. PERRICONE MD 8.2.15.1. Company overview 8.2.15.2. Financial performance 8.2.15.3. Product benchmarking 8.2.15.4. Strategic initiatives 8.2.16. THE BEAUTYHEALHTH COMPANY 8.2.16.1. Company overview 8.2.16.2. Financial performance 8.2.16.3. Product benchmarking 8.2.16.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(cosmetics)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|